Avadel Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 10th

DUBLIN, Ireland, July 27, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, August 10, 2020, to provide a corporate update and discuss the Company’s financial results for the second quarter ended June 30, 2020.
To access the conference call, investors are invited to dial 877-407-9716 (U.S. and Canada) or 201-493-6779 (international). The conference ID number is 13707645. A live audio webcast can be accessed by visiting the investor relations section of the Company’s website, www.avadel.com. A replay of the webcast will be archived on Avadel’s website for 90 days following the event.About Avadel Pharmaceuticals plc:
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is an emerging biopharmaceutical company. The Company’s primary focus is the development and potential FDA approval of FT218, which has completed a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. For more information, please visit www.avadel.com.
Contacts:      Investor Contacts
      Tom McHugh
      Chief Financial Officer
      Phone: (636) 449-1843
      Email: [email protected]
      Tim McCarthy
      LifeSci Advisors, LLC
      Phone: (212) 915.2564
      Email: [email protected]
      Media Contact
      Patrick Bursey
      LifeSci Communications, LLC
      Phone: (646) 970-4688
      Email: [email protected]


Bay Street News

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search